Story at a glance:
- Children between the ages of 12 and 15 may be eligible for Pfizer vaccination soon.
- The vaccination announcement coincides with children socializing during the summer and preparing for school in the fall.
- Pfizer and Moderna are conducting trials for children as young as six months.
Next week, children as young as 12 years old might be authorized to get the Pfizer COVID-19 vaccine.
Pending approval from the Food and Drug Administration (FDA), the Pfizer vaccine is set to become available to adolescents between 12 and 15, The New York Times reported.
The vaccine is currently available to those who are 16 years or older. The report comes as the Biden administration continues its efforts to expand access to vaccines.
The approval would also come as children participate in more summer activities and prepare for the start of school in the fall, the Times notes.
A spokeswoman for the FDA, Stephanie Caccomo, did not provide the Times with a comment on the timing of the agency’s decision.
If the vaccine is granted, the Centers for Disease Control and Prevention (CDC) will need to make new recommendations on how Pfizer can be administered to adolescents.
“We can assure the public that we are working to review this request as quickly and transparently as possible,” Caccomo said.
Pfizer is not the only manufacturer developing a vaccine for adolescents; Moderna is also expected results from a clinical trial on children ages 12 to 17, as well as children 6 months to 12 years old, the New York Times reports. Moderna is currently available for anyone 18 years and older.
Reuters also reports both manufacturers are beginning an early childhood vaccine trial run for those ages 6 months to 11 years old.
Both Pfizer and Moderna require two doses of the vaccine.
READ MORE STORIES FROM CHANGING AMERICA